Connection

Janardan Pandey to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Janardan Pandey has written about Clinical Trials, Phase I as Topic.
Janardan Pandey
Connection Strength
0.089
Clinical Trials, Phase I as Topic
  1. Comment on "Flagellin as an adjuvant: cellular mechanisms and potential". J Immunol. 2011 Feb 01; 186(3):1299; author reply 1299.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.